Evidence map›Paper›PMID 23300913›Full record

ArticlePloS one2012

DNA persistence and relapses questions on the treatment strategies of Enterococcus infections of prosthetic valves.

Jean-Paul Casalta, Franck Thuny, Pierre-Edouard Fournier, Hubert Lepidi, Gilbert Habib, Dominique Grisoli, Didier Raoult

RetractedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. The causative agents in infective endocarditis: a systematic review comprising 33,214 cases.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2016
    Pooled it
  2. Article
  3. Treatment ofAntibiotics (Basel, Switzerland) · 2023
    Review
  4. Impact of Enterococcus faecalis Endocarditis Treatment on Risk of Relapse.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Endocarditis caused by resistant enterococcus: an overview.Current infectious disease reports · 2013
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jean-Paul CasaltaURMITE, Aix Marseille Université, UMR CNRS 7278, IRD 198, INSERM 1095, Faculté de Médecine, Marseille, France.
Franck Thuny
Pierre-Edouard Fournier
Hubert Lepidi
Gilbert Habib
Dominique Grisoli
Didier Raoult
Hôpital de la Timone · FRUnité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes · FRAix-Marseille Université · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We used amplification of the 16S rRNA gene followed by sequencing to evaluate the persistence of bacterial DNA in explanted heart valve tissue as part of the routine work of a clinical microbiology laboratory, and we analyzed the role of this persistence in the relapses observed in our center. We enrolled 286 patients treated for infective endocarditis (IE) who had valve replacement surgery and were diagnosed according to the modified Duke's criteria described by Li et al. from a total of 579 IE cases treated in our center. The patients were grouped based on the infecting bacteria, and we considered the 4 most common bacterial genus associated with IE separately (144 were caused by Streptococcus spp., 52 by Enterococcus spp., 58 by Staphylococcus aureus and 32 by coagulase-negative Staphylococcus). Based on our cohort, the risk of relapse in patients with enterococcal prosthetic valve infections treated with antibiotics alone was 11%. Bacterial DNA is cleared over time, but this might be a very slow process, especially with Enterococcus spp. Based on a comprehensive review of the literature performed on Medline, most reports still advise combined treatment with penicillin and an aminoglycoside for as long as 4-6 weeks, but there has been no consensus for the treatment of enterococcal infection of prostheses in IE patients.

Indexed as

Anti-Bacterial AgentsDNA, BacterialEndocarditis, BacterialEnterococcusGram-Positive Bacterial InfectionsHeart Valve ProsthesisHumansProsthesis-Related InfectionsRecurrenceStaphylococcus aureusStreptococcusAnti-Bacterial AgentsDNA, Bacterial

Identifiers

PMID23300913
PMCPMC3534059
OpenAlexW2046895415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.